NexgenRx Inc.
NXG.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.03M | 712.50K | 480.30K | 454.90K | 189.70K |
| Total Depreciation and Amortization | 213.30K | 212.90K | 215.00K | 232.70K | 171.80K |
| Total Amortization of Deferred Charges | 691.90K | 691.90K | 691.90K | 691.90K | 761.50K |
| Total Other Non-Cash Items | 284.80K | 262.10K | 289.50K | 291.40K | 47.40K |
| Change in Net Operating Assets | -412.40K | -617.90K | -422.20K | -1.05M | -432.00K |
| Cash from Operations | 1.81M | 1.26M | 1.25M | 618.40K | 738.50K |
| Capital Expenditure | -233.70K | -236.60K | -72.40K | -62.40K | -50.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -347.40K | -372.70K | -378.90K | -367.20K | -187.80K |
| Cash from Investing | -581.00K | -609.20K | -451.30K | -429.60K | -238.30K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -127.80K | -125.50K | -115.60K | -102.30K | -98.60K |
| Issuance of Common Stock | 0.00 | 62.50K | 62.50K | 187.50K | 187.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -658.80K | -400.90K | -403.30K | -404.80K | -639.70K |
| Other Financing Activities | 33.00K | 33.00K | 33.00K | 33.00K | -- |
| Cash from Financing | -726.60K | -421.30K | -416.80K | -317.20K | -573.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 501.60K | 231.20K | 386.60K | -128.30K | -73.50K |